63 related articles for article (PubMed ID: 34358382)
1. RBM10-TFE3 fusions: A FISH-concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel cases.
Di Mauro I; Dadone-Montaudie B; Sibony M; Ambrosetti D; Molinie V; Decaussin-Petrucci M; Bland V; Arbaud C; Cenciu B; Arbib F; Just PA; Derman J; Rioux-Leclercq N; Pedeutour F;
Genes Chromosomes Cancer; 2021 Nov; 60(11):772-784. PubMed ID: 34358382
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
[TBL] [Abstract][Full Text] [Related]
3. Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.
Zou H; Kang X; Pang LJ; Hu W; Zhao J; Qi Y; Hu J; Liu C; Li H; Liang W; Yuan X; Li F
Int J Clin Exp Pathol; 2014; 7(1):236-45. PubMed ID: 24427344
[TBL] [Abstract][Full Text] [Related]
4. TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma.
Damayanti NP; Cordova RA; Rupert C; Delle Fontane I; Shen L; Orsi S; Klunk AJ; Linehan WM; Staschke KA; Hollenhorst PC; Heppner DE; Pili R
Cancer Res; 2024 Apr; 84(8):1286-1302. PubMed ID: 38266162
[TBL] [Abstract][Full Text] [Related]
5. A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review.
Zhang R; Ding M; Zhu X; Li X; Hu Q; Tao L; Hu W; Zou H
Diagn Pathol; 2024 May; 19(1):66. PubMed ID: 38730456
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.
Kang XL; Zou H; Pang LJ; Hu WH; Zhao J; Qi Y; Liu CX; Hu JM; Tang JX; Li HA; Liang WH; Yuan XL; Li F
Int J Clin Exp Pathol; 2015; 8(4):3636-47. PubMed ID: 26097545
[TBL] [Abstract][Full Text] [Related]
7. A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma.
Li P; Xu Q; Chen M; Zhu J; Wang Y; Mumin MA; Huang K; Jiang Z; Liang H; Deng Q; Wang Z; Liao B; Chen W; Cao Y; Cao J; Luo J
Cancer Med; 2024 Mar; 13(5):e6813. PubMed ID: 38477529
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Renal Cell Carcinoma Harboring
Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal Melanotic PEComa With NONO::TFE3 Fusion : A Case Report and Letter to the Editor.
Shah AA; Wang S; Shires C; Johnston GA; Billings SD
Am J Surg Pathol; 2024 May; 48(5):634-636. PubMed ID: 38446114
[No Abstract] [Full Text] [Related]
11. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
Guérin R; Menard AL; Angot E; Piton N; Vera P; Schwarz L; Sabourin JC; Laé M; Thiébaut PA
Diagn Pathol; 2024 Apr; 19(1):62. PubMed ID: 38643139
[TBL] [Abstract][Full Text] [Related]
13. Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature.
Lerma LA; Pease G; Malleis J; Antic T; Hes O; Tretiakova M
Hum Pathol; 2024 Mar; 145():26-33. PubMed ID: 38340966
[TBL] [Abstract][Full Text] [Related]
14. Papillary Renal Cell Carcinoma in Transplanted Kidney and Xp11.2 Translocation/Transcription Factor E3-Rearranged Renal Cell Carcinoma in the Native Kidney: A Case Report.
Kim MH; Kim KA; Kim JW; Lee SY; Choi JW
J Korean Soc Radiol; 2024 Mar; 85(2):437-444. PubMed ID: 38617860
[TBL] [Abstract][Full Text] [Related]
15. [2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma].
Bellal S; Kammerer-Jacquet SF; Rioux-Leclercq N;
Ann Pathol; 2024 May; ():. PubMed ID: 38729793
[TBL] [Abstract][Full Text] [Related]
16. TFE3-RCC of the right kidney in an eight-year-old child.
Wu Y; Xie XL; Xiang B
Asian J Surg; 2024 Mar; ():. PubMed ID: 38521744
[No Abstract] [Full Text] [Related]
17. mTOR Inhibition Increases Transcription Factor E3 (TFE3) Activity and Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Translocation Renal Cell Carcinoma.
Lee HJ; Shin DH; Song JS; Park JY; Kim SY; Hwang CS; Na JY; Lee JH; Kim JY; Park SW; Sol MY
Am J Pathol; 2021 Nov; 191(11):1999-2008. PubMed ID: 34358517
[TBL] [Abstract][Full Text] [Related]
18. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
[TBL] [Abstract][Full Text] [Related]
19. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD).
Wu L; Liu Q; Ruan X; Luan X; Zhong Y; Liu J; Yan J; Li X
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509501
[TBL] [Abstract][Full Text] [Related]
20. TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma.
Lin J; Tang Z; Zhang C; Dong W; Liu Y; Huang H; Liu H; Huang J; Lin T; Chen X
Heliyon; 2023 May; 9(5):e16076. PubMed ID: 37215783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
